A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 369 | 2019 |
Test–retest reliability of freesurfer measurements within and between sites: Effects of visual approval process Z Iscan, TB Jin, A Kendrick, B Szeglin, H Lu, M Trivedi, M Fava, ... Human brain mapping 36 (9), 3472-3485, 2015 | 157 | 2015 |
Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy A Cercek, G Dos Santos Fernandes, CS Roxburgh, K Ganesh, S Ng, ... Clinical Cancer Research 26 (13), 3271-3279, 2020 | 145 | 2020 |
SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance I Wasserman, LH Lee, S Ogino, MR Marco, C Wu, X Chen, J Datta, ... Clinical Cancer Research 25 (6), 1948-1956, 2019 | 90 | 2019 |
MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling SB Uppada, S Gowrikumar, R Ahmad, B Kumar, B Szeglin, X Chen, ... Molecular cancer 17, 1-15, 2018 | 74 | 2018 |
A claudin-based molecular signature identifies high-risk, chemoresistant colorectal cancer patients S Gowrikumar, M Primeaux, K Pravoverov, C Wu, BC Szeglin, CEG Sauve, ... Cells 10 (9), 2211, 2021 | 21 | 2021 |
Colorectal cancer develops inherent radiosensitivity that can be predicted using patient-derived organoids KS Hsu, M Adileh, ML Martin, V Makarov, J Chen, C Wu, S Bodo, ... Cancer research 82 (12), 2298-2312, 2022 | 17 | 2022 |
Evaluating the Validity of the Clavien–Dindo Classification in Colectomy Studies: A 90-Day Cost of Care Analysis M Widmar, M Keskin, PD Strombom, RL Gennarelli, BC Szeglin, JJ Smith, ... Diseases of the Colon & Rectum 64 (11), 1426-1434, 2021 | 15 | 2021 |
A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer BC Szeglin, C Wu, MR Marco, HS Park, Z Zhang, B Zhang, ... Cancer Reports 5 (1), e1423, 2022 | 11 | 2022 |
Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion JJ Smith, WK Chatila, F Sanchez‐Vega, J Datta, LC Connell, BC Szeglin, ... Cancer Medicine 8 (15), 6538-6548, 2019 | 9 | 2019 |
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix JK Kim, MR Marco, SH Choi, X Qu, CT Chen, M Elkabets, L Fairchild, ... Molecular Oncology 15 (10), 2766-2781, 2021 | 6 | 2021 |
A rectal cancer model establishes a platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, M Adileh, BC Szeglin, I Wasserman, ... bioRxiv, 640193, 2019 | 2 | 2019 |
Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer F Mokhtari-Esbuie, B Szeglin, MR Ravari, M Duncan, JW Harmon Egastroenterology 1 (2), 2023 | | 2023 |